- Latest available (Revised)
- Original (As adopted by EU)
Commission Implementing Decision (EU) 2016/1100 of 5 July 2016 amending the Annex to Decision 2007/453/EC as regards the BSE status of Costa Rica, Germany, Lithuania, Namibia and Spain (notified under document C(2016) 4134) (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies(1), and in particular the third subparagraph of Article 5(2) thereof,
Whereas:
(1) Regulation (EC) No 999/2001 provides that Member States, third countries or regions thereof (‘countries or regions’) are to be classified according to their bovine spongiform encephalopathy (BSE) status into one of three categories: negligible BSE risk, controlled BSE risk and undetermined BSE risk.
(2) The Annex to Commission Decision 2007/453/EC(2) lists the BSE status of countries or regions according to their BSE risk.
(3) The World Organisation for Animal Health (OIE) plays a leading role in the categorisation of OIE Member Countries and zones by their BSE risk, according to the provisions of its Terrestrial Animal Health Code (Terrestrial Code(3)).
(4) On 27 May 2016, the OIE World Assembly of Delegates adopted Resolution No 20 titled ‘Recognition of the Bovine Spongiform Encephalopathy Risk Status of Member Countries’(4). In addition to the countries previously recognised as having a negligible BSE risk status, that Resolution recognised Costa Rica, Germany, Lithuania, Namibia and Spain as having a negligible BSE risk.
(5) The list of countries or regions in the Annex to Decision 2007/453/EC should therefore be amended to recognise the negligible BSE risk status of these countries.
(6) The Annex to Decision 2007/453/EC should therefore be amended accordingly.
(7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
Commission Decision 2007/453/EC of 29 June 2007 establishing the BSE status of Member States or third countries or regions thereof according to their BSE risk (OJ L 172, 30.6.2007, p. 84).
http://www.oie.int/international-standard-setting/terrestrial-code/access-online/
http://www.oie.int/fileadmin/Home/eng/Animal_Health_in_the_World/docs/pdf/2016_A20_RESO_BSE.pdf
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: